EBIT: Income before interest and taxes.
Blonder Tongue Laboratories, Inc. (BDRL) had EBIT of $-681.58M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$11.16B |
|
$-1.25B |
|
$7.45B |
|
$3.70B |
|
$11.84B |
|
$-681.58M |
|
$-553.65M |
|
$-1.24B |
|
$-1.24B |
|
$-1.25B |
|
$-1.25B |
|
$-1.25B |
|
$-1.25B |
|
|
EBIT |
$-681.58M |
$162.80M |
|
14.44M |
|
14.44M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$3.77B |
|
$91.00M |
|
$5.66B |
|
$9.43B |
|
$6.32B |
|
$2.05B |
|
$4.83B |
|
$11.16B |
|
$-1.73B |
|
$-2.96B |
|
$-1.73B |
|
14.47M |
|
| Cash Flow Statement Financials | |
$1.04B |
|
$-7.00M |
|
$-1.01B |
|
$8.00M |
|
$33.00M |
|
$25.00M |
|
$13.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.60 |
|
-- |
|
-- |
|
6.40 |
|
-2.68 |
|
33.18% |
|
-6.11% |
|
-6.11% |
|
-- |
|
-11.07% |
|
-11.18% |
|
$1.03B |
|
-- |
|
-- |
|
-- |
|
1.18 |
|
3.46 |
|
7.27 |
|
12.37 |
|
72.14% |
|
42.07% |
|
-13.23% |
|
-389.76% |
|
$-119.47 |
|
$71.70 |
|
$71.97 |
|